Rontalizumab (Anti-IFNa1)
Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2664 |
| Sku # | A2664-1mg*5 |
| Pricing | 1mg*5, $970.00 |